Drug Profile
Research programme: glucocorticoid receptor modulators - Sumitomo Pharma
Alternative Names: Nonsteroidal GRMs - Sumitomo PharmaLatest Information Update: 05 Apr 2022
Price :
$50
*
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Sumitomo Pharma
- Class Indoles; Nonsteroidal anti-inflammatories
- Mechanism of Action Glucocorticoid receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Inflammation